OH-PROCTER-&-GAMBLE
Oral-B, the innovation leader in connected brushing and Oral-Care, unveils at the MWC 2019 its breakthrough new Artificial Intelligence Brush GENIUS X, and presents its vision for the future, where intelligent dental & health management tools will lead to a longer, healthier life. Oral-B envisions a world where health monitoring complements consumers’ daily oral health routine and allows them to take care of health comprehensively.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190224005080/en/
Oral-B: The innovation leader unveils its future vision for health at MWC
The mouth is the gateway to health – and a toothbrush touches it twice a day. Oral-B’s future vision is that humans will live longer and healthier through dental care at home. Stephen Squire, Oral-B’s global Brand Director, says: “Imagine: What if a future dental device could tell all you need to know about personal health, and could connect directly with your dental and health professional whenever it’s needed, seamlessly, and as early as possible ?” Oral-B envisions a future that will allow people to undertake at-home health monitoring as part of their daily oral care routine, arming them with real-time feedback to enable diagnosis and prevention. Squire: “The Biometric Health Tracker concept is our idea of a 360-degree health platform, designed to improve oral and overall health. It is not a finished product. It is a vision that shall further enable pioneering work between dental professionals, external researchers and Oral-B scientists alike. Together, we want to explore the endless opportunities connected Oral-Care devices can deliver. ”
NEW Oral-B GENIUS X - Oral-B’s gateway into the future
Oral-B continuously innovates every year to achieve its vision. This year, Oral-B makes a step further to more intelligent dental devices with the NEW Oral-B GENIUS X with Artificial Intelligence. It is Oral-B’s most advanced brush to date. Designed with dental professionals, it does something completely new: It combines the knowledge of thousands of human brushing behaviors to assess individual brushing styles and coach users to achieve better brushing habits. The AI technology tracks where people are actually brushing in their mouth and offers personalized feedback on the areas that require additional attention, for better oral health.
NEW Oral-B GENIUS X - meaningful innovation makes it dentist’s darling
Oral-B’s research with dentists has shown that innovation is successful when it is simple and easy to use. GENIUS X with Artificial Intelligence tech works seamlessly, without having to change your brushing habits or style. It operates in the background. It is so unique because it has learned from thousands of different brushing styles: “Every patient is unique, that is why we are looking for solutions that adapt to the individual. Oral-B gives patients an excellent and personalized brushing experience, without having to change the way they brush to achieve their best oral health result. This makes it a real breakthrough, ” says Prof. Dr. Ralf Rössler from the University for Digital Technologies in Dentistry & Medicine in Luxembourg. GENIUS X with Artificial Intelligence is the first step towards the future, where intelligent devices use data analytics and turn a dental device into the most important element in people’s everyday health routines. Attendees at MWC will be the first to experience Oral-B GENIUS X with Artificial Intelligence and the brand’s future vision.
NEW Oral-B GENIUS X with Artificial Intelligence completes the Oral-B line-up of toothbrushes with a round brush head, helping everyone to brush at their best:
In 2019, Oral-B offers a portfolio where everyone finds the best and most innovative product for his/her special needs:
- Oral-B GENIUS X with Artificial Intelligence, knows how users brush and helps them improve their oral health. Like a fingerprint, Oral-B knows that everyone’s brushing technique is unique. It has learned from thousands of brushing patterns.
- Oral-B GENIUS X with Artificial Intelligence features a new, sleek and modern travel case that charges both the brush and a USB device, such as a smartphone, to make traveling with an electric toothbrush easier than ever.
- Oral-B continues to pioneer connected toothbrushes that help coach and motivate brushers of all ages and backgrounds through the Oral-B App, including the Oral-B Funzone and the Disney Magic-Timer App.
- On average people brush between 30 and 60 seconds – even though they think they do 2 mins. With the App, Oral-B brought the average brushing time to 2 mins and 22 seconds – longer than your dentist recommends.
- Oral-B’s best toothpaste, Gum & Enamel Repair, helps you to prevent future issues.
- Oral-B Teen, Junior and Kids brushes are putting the fun back in brushing.
For more information about Oral-B GENIUS X with Artificial Intelligence, visit https://www.oralb.co.uk/en-gb/product-collections/genius-x .
About Oral-B
Oral-B® is the worldwide leader in the over $5 billion brushing market. Part of the Procter & Gamble Company, the brand includes manual and electric toothbrushes for children and adults, oral irrigators and interdental products, such as dental floss.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190224005080/en/
Contact:
PR Contact: Talisha Holmes MSL talisha.holmes@mslgroup.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 17:46:00 CEST | Press release
Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de
New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 17:44:00 CEST | Press release
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,
LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 17:00:00 CEST | Press release
~New server connects AI assistants directly to test execution data, streamlining debugging and accelerating development~ LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances aut
The Six Winning Projects of the 12th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 16:58:00 CEST | Press release
The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.This year’s edition set a new record: 259 projects submitted from 45 countries.The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened. Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the
Rigaku Completes New Building at Yamanashi Plant27.5.2025 16:00:00 CEST | Press release
Dramatic 2.7-fold increase in floor space to serve global demand Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527974928/en/ Exterior view of the New Building, Yamanashi Plant Doubling of production capacity: a strategic base to support Rigaku’s growth Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom